Only one in four people experience mild systemic side effects from COVID-19 vaccines
2021-04-28
(Press-News.org) One in four people experience mild, short lived systemic side effects after receiving either the Pfizer or AstraZeneca vaccine, with headache, fatigue and tenderness the most common symptoms. Most side effects peaked within the first 24 hours following vaccination and usually lasted 1-2 days.
The study published today in the Lancet Infectious Diseases is the first large scale study to compare the two vaccines and investigate the prevalence of mild side effects of the UK's vaccination programme.
The analysis by researchers from King's College London of data from the ZOE COVID Symptom Study app reassuringly found much fewer side effects in the general population with both the Pfizer and AstraZeneca vaccines than reported in trials.
The study also reports a significant decrease of infection rates from 12 to 21 days after the first dose of the Pfizer (58% reduction) and AstraZeneca (39% reduction) vaccines compared to a control group. The drop in infection at least 21 days after the first dose for Pfizer is 69% and for AstraZeneca 60%.
This large-scale analysis examined the differences of reported side effects from the two vaccines currently distributed in the UK. Systemic effects - meaning side effects excluding where the injection took place - included headache, fatigue, chills and shiver, diarrhoea, fever, arthralgia, myalgia, and nausea; whilst local side effects - meaning side effects where the injection took place in the arm - included pain at the site of injection, swelling, tenderness, redness, itch, warmth and swollen armpit glands.
The data comes from 627,383 users of the ZOE COVID Symptom Study app who self-reported systemic and local effects within eight days of receiving one or two doses of the Pfizer vaccine or one dose of the AstraZeneca vaccine between December 8 and March 10.
Summary of findings:
25.4% of vaccinated people indicated suffering from one or more systemic (excluding the area where the injection took place) side effects, whereas 66.2% reported one or more local (at injection site) side effects.
13.5% of participants reported side effects after their first Pfizer dose, 22.0% after the second Pfizer dose and 33.7% after the first AstraZeneca dose.
The most reported systemic side effect was headache. 7.8% of people reported suffering from headaches after the first Pfizer dose and 13.2% after the second Pfizer dose. 22.8% of people who had the first dose of the AstraZeneca vaccine reported a headache.
The second most reported systemic side effect was fatigue. 8.4% and 14.4% of participants reported fatigue after first and second dose of Pfizer vaccine and 21.1% reported fatigue after their first dose of AstraZeneca vaccine.
The most common local side effect was tenderness: 57.2% and 50.9% after first and second dose of Pfizer vaccine, and 49.3% after first dose of AstraZeneca vaccine
Importantly, this research identifies that side effects were more common among people under 55 years of age and among women.
Also, participants who had a confirmed case of prior COVID-19 were three times more likely to have side effects that effect the whole body after receiving doses of the Pfizer vaccine than those without known infection and almost twice more likely after the first dose of the AstraZeneca vaccine. People with prior known COVID-19 infection were also more likely to experience local effects.
In Phase III clinical trials of the Pfizer vaccine, the most common side effects were pain at the injection site (71-83%), fatigue (34-47%) and headache (25-42%), however the real-world analysis found less than 30% of users complained of injection site pain and less than 10% of fatigue and headache after the first dose. Similarly, in Phase III trials for the AstraZeneca vaccine, systemic side effects were found in 88% of younger participants (18-55 years) after the first dose but this study found a significantly lower rate of 46.2% after the first dose.
While rates of side effects were much lower than expected from clinical trials, rates of infection after vaccine were reassuring after two- three weeks and in line with findings from previous trials and recent data from the Israeli vaccination programme.
Professor Tim Spector OBE, lead scientist on the ZOE COVID Symptom Study app and Professor of Genetic Epidemiology at King's College London said: "The data should reassure many people that in the real world, after effects of the vaccine are usually mild and short-lived, especially in the over 50's who are most at risk of the infection. Rates of new disease are at a new low in the UK according to the ZOE app, due to a combination of social measures and vaccination and we need to continue this successful strategy to cover the remaining population".
"The results also show up to 70% protection after 3 weeks following a single dose, which is fantastic news for the country, especially as more people have now had their second jabs."
Dr Cristina Menni, first author of the study from King's College London said: "Our results support the aftereffects safety of both vaccines with fewer side effects in the general population than reported in the Pfizer and AstraZeneca experimental trials and should help allay safety concerns of people willing to get vaccinated."
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2021-04-28
For the first time, researchers have systematically analysed social and clinical factors associated with psychiatric hospital admission of children and adolescents, finding nearly one-quarter (23.6%) were admitted involuntarily. The study was published in The Lancet Child & Adolescent Health journal.
Researchers also found that children and adolescents who were involuntarily hospitalised were nearly three times more likely to belong to a Black rather than a white ethnic group than those hospitalised voluntarily and more likely to have a diagnosis of psychosis, substance misuse, or intellectual disability.
Involuntary hospitalisation is a legal procedure used to compel an individual to ...
2021-04-28
Neurons result from a highly complex and unique series of cell divisions. For example, in fruit flies, the process starts with stem cells that divide into mother cells (progenitor cells), that then divide into precursor cells that eventually become neurons.
A team of the University of Michigan (U-M), spearheaded by Nigel Michki, a graduate student, and Assistant Professor Dawen Cai in the departments of Biophysics (LS&A) and Cell and Developmental Biology at the Medical School, identified many genes that are important in fruit flies' neuron development, and that had never been described before in that context.
Since many genes are conserved across species such as between fruit flies (Drosophila), mice, and humans, what is learnt in flies can also serve as a model to better ...
2021-04-27
DALLAS - April 27, 2021 - Researchers with the Peter O'Donnell Jr. Brain Institute at UT Southwestern have identified a new protein implicated in cell death that provides a potential therapeutic target that could prevent or delay the progress of neurodegenerative diseases following a stroke.
Scientists from the departments of pathology, neurology, biochemistry, and pharmacology at UTSW have identified and named AIF3, an alternate form of the apoptosis-inducing factor (AIF), a protein that is critical for maintaining normal mitochondrial function. Once released from mitochondria, AIF triggers processes that induce a type of programmed cell death.
In a END ...
2021-04-27
Isaac Newton may have met his match.
For centuries, engineers have relied on physical laws -- developed by Newton and others -- to understand the stresses and strains on the materials they work with. But solving those equations can be a computational slog, especially for complex materials.
MIT researchers have developed a technique to quickly determine certain properties of a material, like stress and strain, based on an image of the material showing its internal structure. The approach could one day eliminate the need for arduous physics-based calculations, instead relying on computer vision and machine learning to generate estimates in real time.
The researchers say the advance could enable faster design prototyping and material ...
2021-04-27
Des Plaines, IL - In a randomized, double-blind trial of patients with acute undifferentiated agitation in the emergency department, droperidol was more effective for sedation and was associated with fewer episodes of respiratory depression than lorazepam or either dose of ziprasidone. This is the conclusion of END ...
2021-04-27
COLUMBIA, Mo. -- Having grown up poor in a rural village in Zimbabwe, Wilson Majee saw firsthand as a child the lack of educational opportunities that were easily accessible and how that impacted the youth in his village.
Now an associate professor in the University of Missouri School of Health Professions, Majee researches the challenges facing disadvantaged, rural youth. He found in a recent study that young people who are disengaged from their communities are much more likely to participate in risky behaviors such as substance abuse, particularly in rural areas that lack educational opportunities.
For the study, Majee spoke with youth in rural South Africa about the factors contributing to drug abuse for the NEET population, which stands ...
2021-04-27
A promising new concept published by an interdisciplinary research team in "Proceedings of the National Academy of Sciences" (PNAS) paves the way for major advances in the field of magnetic resonance imaging (MRI). Their new technique could significantly simplify hyperpolarized MRI, which developed around 20 years ago for observing metabolic processes in the body. The proposal involves the hyperpolarization of the metabolic product fumarate using parahydrogen and the subsequent purification of the metabolite. "This technique would not only be simpler, but also much cheaper than the previous procedure," said leader of the project Dr. James Eills, a member of the research team of Professor Dmitry Budker at Johannes Gutenberg ...
2021-04-27
African waters have been contributing to the global supply of fish for years, with three of the four most productive marine ecosystems in the world near the continent. African countries' Exclusive Economic Zones (EEZs) contributed over 6 million metric tons of fish to the world's food supply, supporting food security and livelihood in the continent, while generating $15 billion to the African gross domestic product in 2011. Every sovereign state has an EEZ, an area of ocean adjacent to their shores in which they have special rights regarding the exploration and use of marine resources.
Industrial fleets from countries around the world have been increasingly fishing in African waters, but with climate change ...
2021-04-27
The risk of developing atherosclerosis - a narrowing of the arteries as cholesterol plaque builds up, leading to obstruction of blood flow - is higher for people with autoimmune rheumatic diseases than for the general population. As a result, they are more likely to have heart attacks and other cardiovascular disorders.
The good news, according to a new study published in Rheumatology, is that regular exercise is a powerful weapon against vascular dysfunction in these patients.
In the article, researchers working in Brazil and the United Kingdom report the results of a systematic review of the scientific literature on the subject. The review, which ...
2021-04-27
SAN FRANCISCO, CA--April 27, 2021--In the 40-some years since the beginning of the HIV/AIDS epidemic, scientists have learned a lot about the virus, the disease, and ways to treat it. But one thing they still don't completely understand is which exact cells are most susceptible to HIV infection.
Without this knowledge, it is difficult to envision targeting these cells to protect the millions of people who encounter the virus for the first time every year, or the infected people in which infection will likely rebound if they go off therapy.
Scientists have known for a long time that the virus homes in on so-called memory ...
LAST 30 PRESS RELEASES:
[Press-News.org] Only one in four people experience mild systemic side effects from COVID-19 vaccines
